Monoclonal B-cell lymphocytosis: Recommendations from the Dutch working group on CLL for daily practice

Netherlands Journal of Medicine

Volumn 70, Issue 5, 2012, Pages 236-241

  te Raa, G D ^a   van Oers, M H ^a   Kater, A P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

CLL; MBL; Practical guidelines

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; CD79B ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN KINASE ZAP 70;

ARTICLE; BLOOD SMEAR; CELL POPULATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL PRACTICE; CYTOGENETICS; DISEASE ASSOCIATION; DISEASE COURSE; FLOW CYTOMETRY; GENE MUTATION; HEPATOSPLENOMEGALY; HUMAN; INFECTION; LYMPHADENOPATHY; LYMPHOCYTE COUNT; LYMPHOPROLIFERATIVE DISEASE; MONOCLONAL B CELL LYMPHOCYTOSIS; MONOCLONAL IMMUNOGLOBULINEMIA; NETHERLANDS; NIGHT SWEAT; PHENOTYPE; PREVALENCE; THROMBOCYTOPENIA; WEIGHT REDUCTION;

B-LYMPHOCYTES; DISEASE PROGRESSION; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTOSIS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE;

EID: 84866093745     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hallek M, Cheson BD, Catovsky D, et al Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111:5446-5456.
2. Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia. 2010;24:512-520.
3. Ghia P, Prato G, Scielzo C, et al Monoclonal CD5+ and CD5-B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood. 2004;103:2337-2342.
4. Rawstron AC, Bennett FL, O'Connor SJ, et al Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008;359:575-5783.
5. Nieto WG, Almeida J, Romero A, et al Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood. 2009;114:33-437.
6. Rawstron AC. Monoclonal B-cell lymphocytosis. Hematology Am Soc Hematol Educ Program. 2009;430-439.
7. Cheson BD, Bennett JM, Grever M, et al National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990-4997.
8. Shanafelt TD, Kay NE, Jenkins G, et al B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood. 2009;113:4188-4196.
9. Shanafelt TD, Kay NE, Call TG, et al MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)? Leuk Res. 2008;32:1458-1461.
10. Rawstron AC, Shanafelt T, Lanasa MC, et al Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom. 2010;78 Suppl 1:S19-S23.
11. Rawstron AC, Villamor N, Ritgen M, et al International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. Leukemia. 2007;21:956-964.
12. Almeida J, Nieto WG, Teodosio C, et al CLL-like B-lymphocytes are systematically present at very low numbers in peripheral blood of healthy adults. Leukemia. 2011;25:718-722.
13. Marti GE, Carter P, Abbasi F, et al B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia. Cytometry B Clin Cytom. 2003;52:1-12.
14. Rawstron AC, Yuille MR, Fuller J, et al Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood. 2002;100:2289-2290.
15. te Raa GD, Fischer K, Verweij W, van Houte AJ, Kater AP, Biesma DH. Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis. Clin Chem Lab Med. 2011;49:115-120.
16. Rossi D, Sozzi E, Puma A, et al The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol. 2009;146:64-75.
17. Shanafelt TD, Kay NE, Rabe KG, et al Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol. 2009;27:3959-3963.
18. Hodgson K, Ferrer G, Pereira A, Moreno C, Montserrat E. Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment. Br J Haematol. 2011;154:14-22.
19. Shanafelt TD, Call TG. Current approach to diagnosis and management of chronic lymphocytic leukemia. Mayo Clin Proc. 2004;79:388-398.
20. Moreira J, Rabe K, Cerhan JR, et al Infectious Complications Among Individuals with Monoclonal B-cell Lymphocytosis (MBL): A Prospective Case-Control Study of Newly Diagnosed Patients. ASH Annual Meeting Abstracts 2011.
21. Platsoucas CD, Galinski M, Kempin S, Reich L, Clarkson B, Good RA. Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies. J Immunol. 1982;129:2305-2312.
22. Porakishvili N, Roschupkina T, Kalber T, et al Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL). Clin Exp Immunol. 2001;126:29-36.
23. Serrano D, Monteiro J, Allen SL, et al Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia. J Immunol. 1997;158:1482-1489.
24. Gorgun G, Holderried TA, Zahrieh D, Neuberg D, Gribben JG. Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. J Clin Invest. 2005;115:1797-1805.
25. Ramsay AG, Johnson AJ, Lee AM, et al Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Invest. 2008;118:2427-2437.
26. Christopoulos P, Pfeifer D, Bartholome K, et al Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL. Blood. 2011;117:3836-3846.
27. Schindhelm RK, van Marwijk Kooy MR, Coenen JL, Huijgens PC, Kuiper-Kramer PA. Monoklonale B-cellymfocytose: fysiologische bevinding of voorstadium van chronische lymfatische leukemie? Ned Tijdschr Geneeskd. 2010;154:1520.
28. Rawstron AC, Jones RA, Ferguson C, et al Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience. Br J Haematol. 2007;139:845-848.
29. Shim YK, Vogt RF, Middleton D, et al Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population. Cytometry B Clin Cytom. 2007;72:344-353.
30. Rachel JM, Zucker ML, Fox CM, et al Monoclonal B-cell lymphocytosis in blood donors. Br J Haematol. 2007;139:832-836.
31. Dagklis A, Fazi C, Sala C, et al The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring. Blood. 2009;114:26-32.
32. Kater AP, Wittebol S, Chamuleau MED, Van Oers MH, Hovon CLL Working Party. Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011. Neth J Med. 2011;69:422-429.